Elevated progesterone during ovarian stimulation for IVF

被引:111
作者
Al-Azemi, M. [2 ]
Kyrou, D. [1 ]
Kolibianakis, E. M. [1 ]
Humaidan, P. [3 ]
Van Vaerenbergh, I. [4 ]
Devroey, P. [4 ]
Fatemi, H. M. [4 ]
机构
[1] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Human Reprod Unit, Sch Med,Dept Obstet & Gynaecol, Thessaloniki 54603, Greece
[2] Kuwait Univ, Fac Med, Dept Obstet & Gynaecol, Safat 13110, Kuwait
[3] Odense Univ Hosp, Fertil Clin, DK-5000 Odense C, Denmark
[4] Dutch Speaking Brussels Free Univ, Acad Hosp, Dept Reprod Med, Brussels, Belgium
关键词
IVF; ovarian stimulation; progesterone rise; origin; prevention; pregnancy; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; INTRACYTOPLASMIC SPERM INJECTION; HUMAN MENOPAUSAL GONADOTROPINS; ASSISTED REPRODUCTION CYCLES; FOLLICULAR PHASE; PREMATURE LUTEINIZATION; SERUM PROGESTERONE; EMBRYO-TRANSFER; INVITRO FERTILIZATION;
D O I
10.1016/j.rbmo.2012.01.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
There is an ongoing debate regarding the impact of premature progesterone rise on the IVF outcome. The objective of this review is to assess evidence of poorer ongoing pregnancy rate in IVF cycles with elevated serum progesterone at the end of follicular phase in ovarian stimulation. It also explores the origin of the progesterone rise, potential modifying factors and possible methods to prevent its rise during ovarian stimulation. This review draws on information already published from monitoring progesterone concentrations at the end of follicular phase in ovarian stimulation. The databases of Medline and PubMed were searched to identify relevant publications. Good-quality evidence supports the negative impact on endometrial receptivity of elevated progesterone concentrations at the end of the follicular phase in ovarian stimulation. Future trials should document the cause and origin of premature progesterone in stimulated IVF cycles. (C) 2012, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 67 条
[1]   SERUM STEROID LEVELS DURING MENSTRUAL-CYCLE IN A BILATERALLY ADRENALECTOMIZED WOMAN [J].
ABRAHAM, GE ;
CHAKMAKJIAN, ZH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (04) :581-587
[2]   SIMULTANEOUS RADIOIMMUNOASSAY OF PLASMA FSH, LH, PROGESTERONE, 17-HYDROXYPROGESTERONE, AND ESTRADIOL-17BETA DURING MENSTRUAL-CYCLE [J].
ABRAHAM, GE ;
SWERDLOFF, RS ;
HOPPER, K ;
ODELL, WD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1972, 34 (02) :312-+
[3]   Endometrial receptivity markers, the journey to successful embryo implantation [J].
Achache, Hanna ;
Revel, Ariel .
HUMAN REPRODUCTION UPDATE, 2006, 12 (06) :731-746
[4]  
Al-Azemi M, 2011, HUM REPROD, V26, pI324
[5]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[6]   Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial [J].
Andersen, Anders Nyboe ;
Devroey, Paul ;
Arce, Joan-Carles .
HUMAN REPRODUCTION, 2006, 21 (12) :3217-3227
[7]   FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect? [J].
Andersen, CY ;
Westergaard, LG ;
van Wely, M .
REPRODUCTIVE BIOMEDICINE ONLINE, 2004, 9 (02) :231-236
[8]   Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome [J].
Bosch, E ;
Valencia, W ;
Escudero, E ;
Crespo, J ;
Simón, C ;
Remohi, J ;
Pellicer, A .
FERTILITY AND STERILITY, 2003, 80 (06) :1444-1449
[9]   Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles [J].
Bosch, E. ;
Labarta, E. ;
Crespo, J. ;
Simon, C. ;
Remohi, J. ;
Jenkins, J. ;
Pellicer, A. .
HUMAN REPRODUCTION, 2010, 25 (08) :2092-2100
[10]   Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer [J].
Bustillo, M ;
Stern, JJ ;
Coulam, CB .
HUMAN REPRODUCTION, 1995, 10 (11) :2862-2867